Bacteremia due to Dietzia maris in an immunocompromised patient
Bacteremia due to Dietzia maris in an immunocompromised patient
复制标题
DOI:
10.1086/313490
复制
发表时间:
1999-11-01
影响因子:
11.8
通讯作者:
Drugeon, HB
中科院分区:
文献类型:
--
作者:
Bemer-Melchior, P;Haloun, A;Drugeon, HB
5. Korting H, Walther D, Riethmuller U, Meurer M. Comparative in vitro susceptibility of Treponema pallidum to ceftizoxime, ceftriaxone and penicillin G. Chemotherapy 1986; 32: 352–5. 6. Hook E, Roddy R, Handsfield H. Ceftriaxone for incubating and early syphilis. J Infect Dis 1988; 158: 881–4.7. Moorthy T, Lee C, Lim K, Tan T. Ceftriaxone for the treatment of primary syphilis in men: a preliminary study. Sex Transm Dis 1987; 14: 116–9. 8. Dowell M, Ross P, Musher D, Cate T, Baughn R. Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med 1992; 93: 481–8. 9. Saxon A, Beall G, Rohr A, Adelman D. UCLA conference: immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med 1987; 107: 204–15.